Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep)
NCT ID: NCT00727935
Last Updated: 2008-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
165 participants
INTERVENTIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaïne
Ropivacaïne
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major parturient (\> 18 years) in the course of work in room of childbirth
* Mono-foetal pregnancy
* Presentation at the top
* Checking of the criteria of pre-inclusion
* Oral confirmation of the assent of the patient
* ASA 1 or 2
* Childbirth by low way
* Patient having an epidural analgesia
* Patient having an episiotomy
* Counter-indication with the ropivacaïne
Exclusion Criteria
* Counter indication with the lidocaïne
* General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used
* Counter-indications with the infiltration: patient under anticoagulants, coagulopathy
* Allergy to the lidocaine or the ropivacaine
* Allergy to the one of analgesics per bones used in the assumption of responsibility of routine
* Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum)
* Minor
* Major protected within the meaning of the law Huriet
* Patient during one time of exclusion following another biomedical study
* Absence of oral confirmation of the assent of the patient
* Infection or ignition of the point of puncture
* Analgesia epidural not functional
* Dural breach
* Appearance of ascribable side effects to only the anaesthetic buildings at the time of epidural analgesia
* Median Episiotomy (increased risk of lesions of the sphincter)
* Need for an instrumentation at the time of expulsion
* Haemorrhage of the delivery requiring a blood transfusion and/or general anaesthesia in urgency with surgical operation for haemostasis
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurent Colbus, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire
Angers, Pays de la Loire Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHU P 2006-03
Identifier Type: -
Identifier Source: org_study_id